Valeant goes for hostile Allergan bid by trying to win over shareholders
In an attempt to try and establish a controlling stake in Botox-maker Allergan, Valeant Pharmaceuticals has offered shareholders a combination of cash and Valeant shares.
News & Analysis on Cosmetics Innovation
In an attempt to try and establish a controlling stake in Botox-maker Allergan, Valeant Pharmaceuticals has offered shareholders a combination of cash and Valeant shares.
Researchers at the Texas Biomedical Research Institute have published research showing in a natural animal model that the malignant melanoma in adulthood is ‘dramatically reduced’ by using sunscreen in childhood.
Following a dismal couple of years for cosmetic giant Avon, could a move like withdrawing from the US market help to recover declining sales?